DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory risks. Learn why DXCM stock is a buy.

Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...

Designing an analog circuit can be a frustrating experience, as noted by Nick Cornford in his Design Idea (DI), “DIY RTD for a DMM.” With a fortnight’s struggle, I completed the design of 4 mA to 20mA ...

Managing diabetes can now be done with blood sugar monitors that don't require a finger prick. A variety of continuous glucose monitors (CGM) can accurately check your blood sugar throughout the day ...

Learn how to perform a MAF delete on your EDC15 engine management system. This guide will walk you through the steps to improve air intake and fuel mapping. #CarTuning #EDC15 #MAFDelete Mary Trump ...

DexCom DXCM received a warning letter from the FDA on March 4, 2025, following inspections of its San Diego and Mesa facilities in 2024. The FDA cited deficiencies in the company’s manufacturing ...

Continuous glucose monitoring (CGM) devices provide real-time blood sugar readings 24 hours a day, allowing people with type 1 or type 2 diabetes to closely track blood glucose levels and trends. Most ...

An interdisciplinary team of researchers from various Chinese universities have developed a miniature-sized continuous glucose monitoring system that works as effectively as market-leading systems.

Aug 26 (Reuters) - Dexcom (DXCM.O), opens new tab said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99. Stelo ...

(Reuters) -Dexcom said on Monday its over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States at a price of up to $99. Stelo was cleared by the U.S. health ...